Aura Biosciences (AURA) Current Assets (2020 - 2026)

Aura Biosciences' Current Assets history runs 7 years deep, the most recent figure standing at $118.5 million for Q1 2026.

• Quarterly Current Assets fell 11.9% year-over-year to $118.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.5 million (down 11.9% YoY) and the FY2025 annual result came in at $149.7 million, down 6.78% from the prior year.
• Current Assets was $118.5 million for Q1 2026 at Aura Biosciences, down from $149.7 million in the prior quarter.
• Across five years, Current Assets topped out at $231.8 million in Q4 2023 and bottomed at $115.9 million in Q3 2022.
• A 5-year average of $165.9 million and a median of $166.2 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets soared 38.88% — and 2025, when it tumbled 36.62%.
• Aura Biosciences' Current Assets stood at $196.7 million in 2022, then increased by 17.84% to $231.8 million in 2023, then sank by 30.7% to $160.6 million in 2024, then retreated by 6.78% to $149.7 million in 2025, then slipped by 20.86% to $118.5 million in 2026.
• Business Quant data shows AURA's Current Assets at $118.5 million in Q1 2026, $149.7 million in Q4 2025, and $170.1 million in Q3 2025.